Jeffrey A. Tornheim - Publications

Analytical Method Development and Validation for Clofazimine in Human Plasma and Application of LC-MS/MS Based Methods for Clofazimine and Bedaquiline in Indian MDR-TB Patients Stratified by HIV Coinfection.

Journal: Journal of mass spectrometry : JMS

Published: May 21, 2026

Impact of undernutrition and diabetes on the pharmacokinetics of first-line anti-TB drugs.

Journal: IJTLD open

Published: February 11, 2026

Evaluation of cycloserine dose regimens in an Indian cohort with multidrug-resistant tuberculosis: a population pharmacokinetic analysis.

Journal: Antimicrobial agents and chemotherapy

Published: September 02, 2025

Quantitation of Plasma Bedaquiline Concentrations in Indian MDR-TB Patients Using Liquid Chromatography-Tandem Mass Spectrometry.

Journal: Biomedical chromatography : BMC

Published: July 03, 2025

Impact of premorbid nutritional status on TB severity.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: June 11, 2025

Latent tuberculosis screening and treatment in solid organ and hematopoietic stem cell transplant candidates and recipients.

Journal: Current opinion in infectious diseases

Published: June 04, 2025

Contribution of Key Comorbidities to Unfavorable Treatment Outcomes Among Adults With Drug-Sensitive Pulmonary TB in India: A Prospective Cohort Analysis.

Journal: Chest

Published: October 28, 2024

Successful Treatment of Carbapenem-Resistant Acinetobacter baumannii Meningitis With Sulbactam-Durlobactam.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: January 14, 2024

Pharmacokinetics of tenofovir alafenamide, emtricitabine, and dolutegravir in a patient on peritoneal dialysis.

Journal: AIDS research and therapy

Published: November 13, 2023

Drug Resistance and Epidemiological Success of Modern Mycobacterium tuberculosis Lineages in Western India.

Journal: The Journal of infectious diseases

Published: August 11, 2023

Two-Year Longitudinal Study Reveals That Long COVID Symptoms Peak and Quality of Life Nadirs at 6-12 Months Postinfection.

Journal: Open forum infectious diseases

Published: August 07, 2023

Swimming against the STREAM: Why STREAM 2 data cannot be easily applied to MDR-TB patients across India.

Journal: Lung India : official organ of Indian Chest Society

Published: May 06, 2023